Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis

In patients suffering from multiple sclerosis (MS), intrathecal injection of triamcinolone acetonide (TCA) has been shown to improve symptoms of spasticity. Although repeated intrathecal injection of TCA has been used in a number of studies in late-stage MS patients with spinal cord involvement, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeflich, Andreas, Fitzner, Brit, Walz, Christina, Hecker, Michael, Tuchscherer, Armin, Bastian, Manuela, Brenmoehl, Julia, Schröder, Ina, Willenberg, Holger S., Reincke, Martin, Zettl, Uwe Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481359/
https://www.ncbi.nlm.nih.gov/pubmed/32982971
http://dx.doi.org/10.3389/fendo.2020.00574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481359/
https://www.ncbi.nlm.nih.gov/pubmed/32982971
http://dx.doi.org/10.3389/fendo.2020.00574

Ejemplares similares